Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

AIMS: Myocardial fibrosis alters the cardiac architecture favouring the development of cardiac dysfunction, including arrhythmias and heart failure. Reducing myocardial fibrosis may improve outcomes through the targeted diagnosis and treatment of emerging fibrotic pathways. The European‐Commission‐f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ESC Heart Fail
Main Authors: Ferreira, João Pedro, Machu, Jean‐Loup, Girerd, Nicolas, Jaisser, Frederic, Thum, Thomas, Butler, Javed, González, Arantxa, Diez, Javier, Heymans, Stephane, McDonald, Kenneth, Gyöngyösi, Mariann, Firat, Hueseyin, Rossignol, Patrick, Pizard, Anne, Zannad, Faiez
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5793978/
https://ncbi.nlm.nih.gov/pubmed/28988439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12218
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares